Wednesday 31 July 2019

Influenza Vaccination Market Opportunities, Challenges, and Applications


Market Scenario
Market Research Future (MRFR) postulates that the global influenza vaccination market is predicted to demonstrate 8.2% CAGR throughout the forecast period (2017-2023). The rising incidences of influenza across the globe is favoring the market growth to a large extent. Influenza is referred to as a contagious respiratory disease which generally affects the human respiratory tract. Symptoms include headache, fever, malaise, cough, body aches, sore throat, and nasal congestion. The most effective way to prevent influenza is a vaccination against it. Also termed as a flu shot, influenza vaccination is used to protect against the influenza virus. The market has witnessed a healthy growth in the recent past owing to the fear of an impending pandemic.
 Market Potential and Pitfalls
With the rising incidences of influenza across the globe, the global influenza market is predicted to propel. Factors such as rising per capita healthcare expenditure and growing immune-compromised geriatric population are highly favoring the market growth. The accelerating awareness associated with the pandemic influenza viruses coupled with the increasing initiatives by the government for vaccination against influenza is contributing to the market growth. A huge amount of unexplored influenza vaccine market in the emerging nations is creating ample opportunities for the market to expand at a rapid pace.
One of the key trends influencing the influenza vaccine market is the development of a strong pipeline. Moreover, the number of clinical trials for developing a vaccine in order to treat influenza is increasing at a steady pace, thereby triggering the demand for influenza vaccination market across the globe. Also, the rising product approval for influenza vaccine is driving the market growth throughout the appraisal period. For instance, Seqirus Vaccine Limited has recently received the FDA approval Afluria Quadrivalent.
On the contrary, strict regulatory framework coupled with the low accessibility of the product especially in the developing economies are some of the major concerns anticipated to limit the market growth during the appraisal period. Moreover, limited production capacity, variable demand, strict mandates which act as a barrier to the new entrants, and a high level of required investment are disrupting the market to a large extent.
Competitive Dashboard
The global influenza vaccine market is highly consolidated with major players dominating the market share. The entry is fairly restricted in the market due to the strict regulatory compliance requirement. The competitive landscape details strategies, products, and investments being done by key players in different technologies and companies to boost their market presence.
Global Influenza Vaccination Market: Segmental Analysis
The global influenza vaccination market has been segmented on the basis of manufacturing technology, type of influenza, vaccines, and others.
By mode of type of influenza, the global influenza vaccination market has been segmented into pandemic, seasonal, zoonotic, and others.
By mode of manufacturing technology, the global influenza vaccination market has been segmented into cell culture based, egg-based, recombination-based technology, and others.
By mode of vaccines, the global influenza vaccination market has been segmented into FluMist, Fluzone, fluvirin, fluvax, and others.
By mode of end-users, the global influenza vaccination market has been segmented into research organization, hospital & clinics, academic institutes, and others.
Regional Insights
Geographically, the influenza vaccination market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.
Among all the regions, the American region is predicted to dominate the global Influenza Vaccination Market due to the growing prevalence of influenza coupled with the high per capita healthcare expenditure. Additionally, with the presence of developed economies like Canada and the U.S., the market in this region is predicted to expand in the coming years. Moreover, the rising geriatric population is likely to fuel the market growth.
The European region is considered to occupy the second largest market share and is likely to retain its dominance. The growth is credited to the high availability of funds for research, a huge patient population, and well-developed healthcare infrastructure. With the presence of market players such as Novartis AG and F. Hoffmann-La Roche Ltd, the market is estimated to propel.
On the other hand, the Asia Pacific region is presumed to experience the fastest growth rate owing to the presence of developing nations such as China and India. Additionally, with the rising geriatric population coupled with the favorable government policies, the market in this region is estimated to flourish.
Industry Updates
February 12, 2019: M2SR, an intranasal vaccine candidate has shown for the first time, protection against an extremely mismatched influenza virus. FluGen Inc. announced that despite the mismatch, more than 50 percent of the participants who received M2SR had shown a serum antibody response to the vaccine.
Hottest Trending Reports
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com 
Posted by at No comments:
Labels: , ,

Healthcare Biometrics Market Sees Promising Growth by 2023 According to New Research Report

Healthcare Biometrics Market Research Report - Global Forecast to 2022
Market Research Future recently presented Global Healthcare Biometrics Market study with detailed review, portraying about the Product/Industry Scope and expounds market outlook and status to 2022.
Biometrics after garnering huge prominence in banking, insurance, and public security sector, are all set to revalorize healthcare sector. Healthcare (HC) officials can leverage some unique approaches using the biometrics techniques such as facial recognition solutions, fingerprint scanners, palm vein readers, and iris scanners among others, in combination with their smartphones.
Implementing these emerging technologies makes it easier for hospitals, practices, payers and other healthcare organizations to recognize individual patients and match an individual's medical data which holds considerable promise. As a result, healthcare biometrics (HB) market is growing pervasively and rapidly.
Recognizing the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global healthcare biometrics market is expected to evaluate at USD 5.6 BN by 2022, registering a whopping CAGR of 22.3% during the forecast period (2016 – 2022).
Factors such as spreading awareness about HB technologies and their increasing applications across the healthcare sector along with the proliferating HC insurance market is driving the market of biometrics in healthcare.
Additional factors substantiating the market growth include the growing population, and extensive penetration of healthcare facilities, worldwide. Rapidly improving economic conditions are positively impacting the market growth, availing quality care and insurance facilities, across the globe.
Although biometric technologies have long held promise leveraging, identification of patients and employees, these have been slow to catch on in healthcare. Surely, many hospitals and clinics have implemented some technologies; however, biometrics is not yet entirely in the mainstream of healthcare practices. These factors might obstruct the market growth.
Patient identification and matching is an ongoing healthcare problem worldwide, and, especially in developed regions where the law prohibits the standard identifier, it is made even more complicated, and interoperability and record matching issues are still intimidating HC officials to varying extents. However, with time and seminal efforts put in by healthcare CISOs and biometrics technology vendors, HB is soon expected to get in the mainstream.
Key Players
Some of the eminent leaders of the market include 3M Cogent Inc., Fujitsu Limited, BioEnable Technologies, Morpho (A Subsidiary of Safran SA), NEC Corporation, Bio-Key International, Inc., Crossmatch Technologies Inc., Suprema, Inc., Integrated Biometrics, and Imprivata Inc.
Global Healthcare Biometrics Market   - Segments
MRFR has segmented its analysis into four key dynamics for enhanced understanding.
By Technologies    : Face Recognition, Fingerprint Recognition, Vein Recognition, Behavioral Recognition, Iris Recognition, and Palm Geometry Recognition among others.
By Applications     : Patient Identification, Patient Monitoring, Medical Record Management, Data Security, and others.
By End-users           : Hospitals, Research Laboratories, and Healthcare Institutes among others.
By Regions              :  Europe, North America, APAC and the Rest-of-the-World.
Global Healthcare Biometrics Market – Geographical Analysis
Globally the North American region accounts for the largest market for healthcare biometrics mainly due to the well-established healthcare sector and the augmenting demand for regulatory requests. Simultaneously, some factors such as increasing digital advancements in medical technology, extensive uptake of healthcare biometrics in hospitals, along with the presence of the proliferating healthcare insurance industry are propelling the market growth in the region.
Also, demand for user-friendly software along with the importance of electronic medical records contributes to the market growth. The US backed with the developments in authentication solutions, patient identification, medical record management, patient monitoring, and data security, majorly supports the market growth in the region.
The European region is another lucrative market for healthcare biometrics standing at the second position. The market is heading with the augmenting demand for HB across the region. Undoubtedly, the resurging economy in the region is a dominant factor substantiating the market growth, increasing healthcare facilities.  Also, the increased funding in the rising numbers of the medical record management concerns, especially in the field of Insurance are providing impetus to the market growth in the region.
The healthcare biometrics market in the Asia Pacific region is rapidly emerging as a promising market.  Burgeoning healthcare sector along with the rapidly developing biometric models and technologies defines the market landscape in the region. Furthermore, rapidly improving economic conditions along with the market penetration of healthcare technology in the region provide impetus to the market growth. The healthcare biometrics market in the APAC with some of its untapped regions offers high growth opportunities.
Global Healthcare Biometrics Market   - Competitive Landscape
Highly competitive Healthcare Biometrics market appears to be fragmented owing to the presence of several big & small market players along with new entrants churning the competition. Key players are adopting the strategic trends for business expansion in the emerging markets. Key market players are focusing on optimized situational awareness for customers, ensuring their mission success. Matured players, through various strategies such as collaboration, M&A activities, and innovations are continually seeking market expansion.
They increasingly invest in R&D activities and to develop cost-effective product portfolio. These players possess state of the art facilities to develop software and strong sales and distribution network which have helped them to gain the leadership position in the market. Marketers operating in the Clinical Practice Management industry are focusing on inbound lead generation more than ever.  Industry’s marketing executives look for ROI-oriented strategies that can pay off quickly.
Table of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Healthcare Biometrics Market by Technology
...

Healthcare Trending Reports
About Us
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: , , ,

Worldwide Parotid Tumors Market Will growing at a CAGR of Approx. 7% during 2017-2023

Market Scenario
According to a new report by Market Research Future (MRFR), the market for global parotid tumors is anticipated to expand at 7.1 % CAGR during the assessment period (2017-2023) owing to the growing prevalence of cancer. The parotid glands are prone to parotitis, injury, fibrous reaction, parotid tumors, and cancers. Parotid tumors are abnormal growth within the salivary gland and can be both cancerous as well as non-cancerous. They are caused by liver cirrhosis, abdominal surgery, salivary gland infections, dehydration, salivary duct stones, and metastasis of cancer.


Drivers and Constraints Affecting the Market
The human body consists of two parotid glands on either side of the face. The growth of the tumors are generally slow and benign, but in seldom cases, the growth can be malignant. Increasing consumption of alcohol, growing liver cirrhosis, and increasing prevalence of cancer are some of the major factors driving the market over the assessment period. With the growing demand for advanced technologies, government support and initiatives, and the presence of growing market players, the market for parotid tumor is anticipated to expand at a staggering rate over the review period. For instance, according to Cancer Research U.K., over 14.1 million cancer cases were diagnosed in the year 2014. According to the national cancer institute, over 14.5 million cancer cases went undiagnosed in the year 2014. Such statistics have pushed the number of cancer cases and are likely to spur the market growth over the review period.
However, complications such as facial nerve paralysis, hemorrhage or hematoma, infection, cosmetic deformity, and others arising after the required treatment are supposed to hinder the growth of the global parotid tumor market.

Global Parotid Tumor Market: Segmental Analysis
Globally, the parotid tumor market has been segmented on the basis of treatment, type, diagnosis, and end-users.
The market has been segmented into Warthin's tumor, pleomorphic adenoma, pleomorphic adenoma, and cancerous/malignant tumor based on type. In most cases, parotid tumors are benign, but in seldom cases the tumors are cancerous. Pleomorphic Adenoma is the most common type of benign parotid tumor which is also termed as benign mixed tumor. A pleomorphic adenoma might grow if not removed or left untreated.
The market has been segmented into removal of lymph node, parotidectomy, radiation therapy, reconstructive surgery, and chemotherapy based on treatment. Surgical procedures require complete or partial removal of parotid gland; a common procedure being parotidectomy.
The market has been segmented into X-ray, CT scan, MRI, ultrasound, fine needle aspiration cytology (FNAC), sialography, and others based on diagnosis.
The market has also been segmented into specialty centers, hospitals, and research centers based on end-users.

North America to Dominate the Market
Geographically, the market for parotid tumor has been spanned across North America, Europe, Asia Pacific, and the Middle East and Africa. Among these, the North American region is predicted to be the growing market in the American region. Growing consumption of alcohol among the crowd coupled with the increasing number of cancer is anticipated to drive the market in this region. Moreover, with the rising expenditure on healthcare the market is expected to expand over the assessment period. For instance, as per National Institute on alcohol abuse and alcoholism, around 26.9 % individuals above 18 years of age consume alcohol. According to Agency for Healthcare Research and Quality, over USD 80.2 billion was spent in treating cancer.
The European region is projected to hold a noticeable share and is expected to be the second largest market after North America. Due to the availability of advanced treatment coupled with skilled medical professionals and growing need for healthcare infrastructure, the market in this region is expected to witness a healthy growth.
On the other hand, Asia Pacific is anticipated to be the fastest growing market over the review period owing to the growing prevalence of chronic diseases. India is one of the fastest regions due to increasing population. Availability of new treatment methods and growing concern about health is expected to drive the market in this region.
The Middle East and Africa are estimated to show the least growth rate due to lack of awareness and limited access to treatment facilities. The United Arab Emirates is the largest market in the Middle East owing to the availability of specialty care centers and development of healthcare industry.

Industry News
Atlantic Health System’s new Atlantic HPV Center will begin a study to determine whether an innovative combination of immuno-oncology treatments is safe, shows preliminary efficacy and provokes an anticancer immune system response in patients with recurrent or metastatic human papillomavirus (HPV) associated head and neck squamous cancer. Recent evidence proves that several cases of squamous head and neck cancer which was previously caused due to smoking might now be caused by sexually transmitted HPV.
Competition Analysis
The prominent players operating the market for parotid tumors are Novartis AG, Pfizer Inc., Bristol-Myers Squibb, Janssen Global Services LLC, Bayer AG, Hoffmann-La Roche Ltd, Merck & Co. Inc., Eli Lilly & Co, and others.

Related Reports:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:

Monday 29 July 2019

Intelligent Pills Market Booming With Highest CAGR By 2023

Intelligent Pills Market – Overview
Intelligent Pills/ Smart Pills further to its invention in 2012 have evolved with technology in the pharmaceutical field solving problems that have overwhelmed the healthcare industry for decades and improving overall therapeutic effectiveness. Tiny ingestible sensors in Intelligent Pills using Bluetooth, established communication with an adhesive pad patients wearing on their chests  the real-time data is then shared on associated Smartphone app that passes the readings to doctors, family members and caretakers alike. This ultimately helps in dealing with the medication adherence issues that further lead to many health problems worldwide, that restricting the therapeutic effectiveness of medicines which account for a substantial amount of money causing unnecessarily increasing span of treatment. Due to this tremendous efficacy Intelligent Pills are increasingly gaining popularity consecutively its market value is ascending pervasively on the global platform further opening galore opportunities for the healthcare sector to evolve and grow.
Accrediting the sedulous work of the key players & researchers, bringing novelties in Intelligent Pills and helping its market to gain increasing traction and grow widely, the Market Research Future has recently published a meticulous study report, giving out the complete market prognosis up to 2027. According to which, the Global Intelligent Pills Market is expected to grow further continuing with the same trend over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value.
Factors that predominantly drive the Intelligent Pills market growth include rising awareness about Intelligent Pills among the patients and doctors alike. Additionally, Presence of large number of geriatric population that needs timely medication but tend to forget at times is anticipated to fuel the market growth of Intelligent Pills. Schizophrenia patients & patients with mental disorders, who are incapable to keep a log of their medications or tend to be reckless towards or sometimes even deny medications completely, this worsens the scenario. Such patients actually need intensive care & regularities of medication and their caregivers are overwhelmed by trying to manage the gamut and desperately wish for having some alternative method and assistance for recording the readings. In such cases Intelligent Pills are reliably helping their care givers & family members to keep a tab on patients’ medications. Therefore, increasing number of Schizophrenia patients & patients with mental disorders is expected to provide extensive impetus to the Intelligent Pills market growth owing to the reliable assistance it provides.
On other hand lack of awareness towards befits of Intelligent Pills coupled with the scepticism of physicians are posing challenges to the Intelligent Pills market growth. The high manufacturing cost and complexity of production, along with the unclear regulatory policies in many countries are expected to pose as major constraints for the global Intelligent Pills market during the forecast period. Alternatively, technological advancements coupled with growing number of pharma companies that can manufacture Intelligent Pills on a high production rate is expected to bring the production cost down, this factor is expected to escalate the Intelligent Pills market growth to the next level during the forecasted period.
Key Players for Intelligent Pills Market:
Some of the key players in this market are:
  • CapsoVision, Inc. (US)
  • Given Imaging Ltd. (Israle)
  • Medimetrics (Mexico)
  • (Bio-Images Drug Delivery) BDD LTD (UK)
  • Proteus Digital Health (US)
Intelligent Pills Global Market – Competitive Analysis
The Global Intelligent Pills Market is driven by some of the prominent players including CapsoVision, Inc. (US), Given Imaging Ltd. (Israle), Medimetrics (Mexico), (Bio-Images Drug Delivery) BDD LTD (UK), and Proteus Digital Health (US) among others. Acknowledging, the sedulous work of these key players, MRFR profiles them in its market analysis.
The global market of Intelligent Pills appears to be moderately competitive and consolidated with the limited number of key players operating in the market with the presence of several well-established and small players. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market. Top players are investing heavily in R&D and clinical trials to develop effective Intelligent Pills.
Industry/Innovation/ Related News:
November 14, 2017 - The Food and Drug Administration approved the Intelligent Pill called Ability, or medication with a sensor. Japanese drug maker Otsuka Pharmaceutical won the approval for ‘ Ability’, prescribed to adults for bipolar disorder, schizophrenia mania and some forms of depression.
September 12, 2017 -   Researchers at Caltech (US) presented their study foe the prototype miniature medical device that they have developed which could ultimately be used in "smart pills" to diagnose and treat diseases. A key to the new technology—and what makes it unique among other microscale medical devices is that its location can be precisely identified within the body, something that proved challenging before.
February 17, 2017 - Eindhoven University of Technology (South Netherlands) Researchers presented a new method that should enable controlled drug delivery into the bloodstream using DNA computers. The team developed the first DNA computer capable of detecting several antibodies in the blood and performing subsequent calculations based on this input. This is an important step towards the development of smart, 'intelligent' drugs that may allow better control of medication with fewer side-effects and at lower cost.
Intelligent Pills Global Market – Segmentation
The Intelligent Pills Market is segmented in to 3 key dynamics for the convenience of the report and enhanced understanding;
Segmentation ByApplication         : Comprises Sleeping disorders, capsule endoscopy, Reflux Monitoring, Mobility Monitoring, Stress Management, and others.
Segmentation By Prescription       : Comprises Prescription Smart Drugs and others.
Segmentation ByRegions              : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Thursday 25 July 2019

​Bronchoscopes Market – Improvement in Technology is Expected to Drive the Growth

Bronchoscopes Market Market Synopsis:
The rapid incorporation of advanced technology and multi-functioning devices in medical practices has simplified the complex diagnosis and treatment procedures of various diseases. Bronchoscope is one such device that is extensively used for carrying out endoscopic procedures on an individual’s respiratory tract. According to the report that has been published by Market Research Future (MRFR), the global bronchoscopes market is anticipated to expand at a robust CAGR of 7.4% during the forecast period of 2016-2023 and is estimated to reach USD 2,244.4 Mn by the end of 2023.
Bronchoscopes Market Competitive Analysis:
Rising demand for advanced medical devices has created multiple opportunities for the manufacturers to develop innovative technologies and introduce upgraded products in the global bronchoscope market. The strategic mergers and acquisitions are aiding the market players for expansion of their businesses in the global bronchoscopes market. These initiatives are strengthening the competition among prominent players in the global bronchoscope market.
The prominent players in the global bronchoscope market are Ambu Inc. (US), Boston Scientific Corporation (US), Cogentix Medical (US), Olympus Corporation (Japan), Fujifilm Holdings Corporation (Japan), Pentax Medicals (Japan), LocaMed (UK), Vimex Sp. (Poland),  KARL STORZ GmbH & Co. KG (Germany), Schindler Endoskopie Technologie Gmbh (Germany), Schölly Fiberoptic Gmbh (Germany), Hangzhou EndoTop Medi-Tech Co., Ltd.(China) and  Guangzhou MeCan Medical Limited (China).
Bronchoscopes Market Drivers and Restraints:
Increasing prevalence of respiratory diseases and lung cancer are inducing high demand for technologically advanced diagnostic devices in the global market. Improvement in the healthcare infrastructure and increasing research and development expenditure for introduction of efficient and minimal invasive diagnostic and treatment techniques are driving the global bronchoscopes market.
Wide spread application of bronchoscopes for visual diagnostic purposes such as to view abnormalities in the respiratory tract, to obtain tissue specimens from lungs by biopsy and to evaluate lung bleeding, possible lung cancer, chronic cough and others are fueling the growth of the global bronchoscopes market.
Advancement in medical technology has led to the development of flexible bronchoscopes that are being used for therapeutic purposes such as removal of secretions, blood or foreign objects obstructing the air flow in respiratory tract, which is resulting in the expansion of the global bronchoscopes market. On the flipside, risk of infection, damage to vocal cord and pneumothorax caused during bronchoscopy are likely to create hindrance in the growth of the global bronchoscope market during the forecast period.
Market Segmentation:
The global bronchoscope market has been segmented on the basis of type, application and end-users. Based on type, the bronchoscope market is segmented into rigid bronchoscope and flexible bronchoscope. Recent developments in bronchoscope technology have led to the significant growth of flexible bronchoscope segment in the global bronchoscope market.
Based on application, the bronchoscope market is segmented into diagnosis and surgical procedures. The diagnosis segment includes examination and obtain tissue specimen for biopsy. The surgical procedure segment include removal of foreign object in the airway, laser resection of tumors, lung abscess, stent insertion, percutaneous tracheostomy and tracheal intubation.    
Based on end users, the bronchoscope market is segmented into hospitals and clinics, diagnostic centers, and others.
Global Bronchoscopes Market – Regional Analysis
North America heading with the increasing government support for research & development, leads the global Bronchoscopes market.  Factors such as the presence of a huge patient population and well-developed healthcare sector alongside the high healthcare spending foster the growth of the market.
The US, among other North American countries, backed by the increasing healthcare spending, heads the regional market. The North America bronchoscopes market is expected to reach USD 868.7 MN by 2023, registering over 7.4 % CAGR during the forecast period.
The bronchoscopes market in the European region accounts for the second largest market, globally. Factors such as high healthcare spending and the presence of a well-developed healthcare sector drive the growth of the regional market. 
Furthermore, factors such as the rising government support for the R&D activities in the life science domain are substantiating the growth of the market in the region. Led by the increasing prevalence of respiratory diseases, the bronchoscopes market in Europe is expected to grow at a CAGR of 6.9% throughout the forecast period.
The Asia Pacific bronchoscopes market is emerging as a profitable market globally. Factors that are fostering the growth of the regional market include significant advancements in the field of biotechnology and the increasing government support for the R&D activities required for the development of bronchoscopes.
Additionally, rising healthcare expenditure and rapidly increasing awareness about the availability of the treatment are some of the factors driving the growth in the regional market.
Industry Update:
On 15th May 2018, Auris Health, a robotic medical company, has announced that it has signed a co-operative development and commercialization agreement with NeuWave™ Medical, Inc., for integration of NeuWave™ Flexible Microwave Ablation Technology with Auris’s Monarch™ platform. This collaboration with a subsidiary of Ethicon, Inc., and part of the Johnson & Johnson Medical Devices Companies was done to enable robotically assisted bronchoscopic ablation of lesions in the lung
Healthcare Industry Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Tuesday 23 July 2019

Prostate cancer Market to See Stunning Growth by 2023 | Size, Share, Analysis and Trends

Global Prostate cancer Market – Overview
The global prostate cancer market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.


Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist).
Progenics Pharmaceuticals, Inc., 2015, acquired Exini Diagnostics AB in order to support its imaging and therapeutic agents with sophisticated analytical tools and other technologies to help patients and physicians understand, target and treat prostate cancer. These companies are more investing in research and development program to provide the best treatment option, which help them to keep ahead with their competitor.
These acquisitions help companies to provide better treatment opportunity in the market and hence improve the quality of life for the people around the world. Additionally it help market players in translating breakthrough science into innovative treatment to help people with prostate cancer worldwide.
Key Players:      
OncoGenex Pharmaceuticals Inc. (U.S.), Bayer Pharma AG (Berlin), Progenics Pharmaceuticals, Inc. (U.S.), Tolmar Inc. (U.S.), OncBioMune Pharmaceuticals Inc. (U.S.), Endo Pharmaceuticals Inc. (U.S.), Tokai Pharmaceuticals, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of prostate cancer, globally.
Prostate cancer is the most common non skin cancer, which affects the gland that produces some of the fluid in semen and plays an important role in controlling urine of men. This is one of the most common type of cancer in men, which grow slowly and is initially confined to prostate gland, where it may not cause serious harm. According to estimate done by the American Cancer Society, in 2017, there will be around 161,360 new diagnoses of prostate cancer, and that around 26,730 fatalities will occur because of it.
Global Prostate cancer Market   - Regional Analysis
According to Prostate cancer Foundation, it is the most common type of cancer in United States. The Older you are more chance of getting diagnosed with prostate cancer. 1 in 8 men get diagnosed with this type of cancer at some points of age.
According to American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will get diagnosed and around 26,730 death occurs owing to prostate cancer in United States. Report suggest more than 2.9 million men get diagnosed with prostate cancer at some point are still alive today. The market of prostate cancer is much higher in the Americas region attribute to high rate of obesity population. The government have more focus towards research and development for introducing the best treatment for their population.
Europe is also consider huge market for prostate cancer market players, owing to present of huge population affected with disease. Company in this region have well developed treatment option, whereas developing countries are more focus to obtain well developed treatment in order to provide best treatment to their citizen. Thus, players are involve in exporting the advanced treatment and maximizing the profit by capturing market share of Asia Pacific. Government are more focusing to educate their public in order to minimize the patient’s population by educating them about the side effect of unhealthy diet, obesity etc.
Asia Pacific region are considering the growing market, owing to presence of huge population suffering with prostate cancer. Whereas country like India and china are considering fastest growing region due to the high rate of obesity population which leads the incidence of prostate cancer, additionally they are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their citizen. Whereas the Middle East and Africa have low market due to his incapability of investment, Moreover developing countries are still focusing on new drugs for the treatment of prostate cancer, this gap between the developed and developing countries will present significant growth opportunity for the prostate cancer treatment market players in the coming years.
 Intended Audience:
  • Companies related to Prostate cancer
  • Government research Laboratories
  • Research and Development (R&D) Companies
  • Independent Research Laboratories
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Latest Trending Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for Asia Pacific, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Sunday 21 July 2019

Kidney Dialysis Equipment Market Size, Share, Analysis and Trends : Latest Update

The market report “Global Kidney Dialysis Equipment Market 2019” offers vital insights on every market segment in terms of market size analysis for Industry across the different regions.
 Kidney Dialysis Equipment Market - Overview
The Global Kidney Dialysis Equipment Market is touted to accumulate USD 16.5 billion at a stupendous 5.7% CAGR during the assessment period (2018-2023). CKD or chronic kidney disease is a chronic condition which seriously impacts a patient’s quality of life.
Kidney dialysis is the most preferred treatment for severe conditions where both the kidneys of a person is damaged but this treatment is also occasionally used for treating patients with a single damaged kidney.
Every day, the kidney of a healthy person filters about 150 quarts of blood. Should an individual’s kidney fail to function efficiently automatically the waste will get collected in the blood resulting in coma and even death.
Here dialysis will act as the savior. It will stop the toxin and waste products formation in the blood. It is an artificial kidney that is used for filtering the blood of the patient during kidney failure, kidney dysfunction and kidney damage and for removing surplus impurities from kidneys.
FREE SAMPLE COPY OF “Kidney Dialysis Equipment Market Research Report – Forecast to 2023” @ https://www.marketresearchfuture.com/sample_request/6302
There are many factors that is driving the growth of the kidney dialysis equipment market. Some of these factors as per the Market Research Future (MRFR) report include new funding channels in the healthcare sector, increase in the prevalence of dialysis patients, better healthcare infrastructure, adoption of latest technologies in dialysis, loss of appetite causing weight loss, change in sedentary lifestyle, heart failure, growing acidosis, growing number of ESRD (End Stage Renal Disease Patients), increase in accurate and cost-effective portable dialysis apparatus, fast growth in geriatric population, growing frequencies of hypertension and diabetes problems and preference for dialysis over kidney transplantation.
On the contrary, factors such as difficulties and risks involved, time consumption, regulations and rules associated with dialysis, expensive treatments and soaring cost of dialysis procedures may take a toll on the growth of the kidney dialysis equipment market over the assessment period.
Leading Key Players
Leading players profiled in the kidney dialysis equipment market include Hemoclean CO., LTD, Teleflex Incorporated, Rockwell Medical, Terumo Corporation, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Nxstage Medical, Inc., Nipro Corporation, Diaverum Deutschland GmbH, B. Braun Melsungen AG, Baxter International Inc., Davita Healthcare Partners Inc and Fresenius Medical Care AG & Co. Ka.
Feb 2019- Leading dialysis service provider, US Renal Care, Inc will be acquired by Investor Group with an aim to improve the quality of life for those having chronic renal disease.
April 2018- MRCS (Malaysian Red Crescent Society) and KDC (Kidney Dialysis Centre) off late has received accolades for their success to help countless patients in the last 22 years.
Kidney Dialysis Equipment Market – Segments
The global kidney dialysis equipment market has been segmented on the basis of type, apparatus, type, and end-user. On the basis of type, the market has been classified as hemodialysis, peritoneal dialysis, and Continuous Renal Replacement Therapy (CRRT).
Hemodialysis is segmented into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD), Continuous Cycling Peritoneal Dialysis (CCPD), Intermittent Peritoneal Dialysis (IPD), and Tidal Peritoneal Dialysis (TPD).
On the basis of apparatus type, the market has been classified into hemodialysis equipment, peritoneal dialysis equipment, and consumables and continuous renal replacement therapy systems. The hemodialysis equipment is segmented into hemodialysis machine, dialyzers and filters, bloodline system, concentrates and solutions, tunneled hemodialysis catheters, and vascular access devices.
The peritoneal dialysis equipment is segmented into concentrates and solutions, automated peritoneal dialysis machines, dialyzers, and filters. On the basis of end-user, the market has been classified into hospitals, clinics, in-center dialysis settings, home care, and ambulatory services.
Kidney Dialysis Equipment - Regional Analysis
Based on region, the kidney dialysis equipment market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America is likely to command the market owing to the rising incidence of kidney failure, rising cases of diabetes and hypertension and higher reusable income amid people.
Europe will have the second biggest share due to advanced medical compensation and progressive organizations.
The kidney dialysis equipment market in APAC possess an unprecedented market potential owing to increasing incidences of kidney failure, increase in disposable income, presence of large geriatric population and low rates of organ transplantation. The kidney dialysis equipment market in the Middle East and Africa will have minimal share owing to low per capita income and stringent government policies.
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:
Labels:

Thursday 18 July 2019

Cancer Diagnostics Market Anticipated to Grow at a Significant Pace by 2023

Global Cancer Diagnostics Market: Synopsis
The detailed report that has been recently published by Market Research Future (MRFR) projects that the global cancer diagnostics market is marked to exhibit noteworthy expansion at a CAGR of 11.85% during the forecast period of 2017-2023. Rise in prevalence of individuals suffering from cancer and high demand for advanced diagnostic procedures in order to receive precise and effective treatment are majorly propelling the growth of the global cancer diagnostic market. Increasing availability of diagnosis solution in the healthcare sector in the developed and developing regions and rise in government initiatives to spread awareness in the underdeveloped regions are also fueling the growth of the global cancer diagnostics market.


Global Cancer Diagnostics Market: Key Players
The prime players profiled by MRFR that are operating in the global cancer diagnostics market are Armune BioScience, Inc. (the U.S.), Arquer Diagnostics Ltd (the U.K), BioMark Diagnostics Inc. (Canada), Biotheranostics, Inc. (the U.S.), Cancer Diagnostics, Inc. (the U.S.), Agilent Technologies, Inc. (the U.S.), Thermo Fisher Scientific, Inc. (the U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (the U.S.), GE Healthcare (the U.K), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (the U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (the U.K.), and C.R. Bard, Inc. (the U.S.).

Global Cancer Diagnostics Market: Segmental Analysis
The global cancer diagnostics market has been segmented on the basis of types, application, and end user. Based on type, the global cancer diagnostics market has been segmented into biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics, and others. Based on application, the global cancer diagnostics market has been segmented into lung cancer, breast cancer, colorectal cancer, cervical cancer, prostate cancer, skin cancer, blood cancer, kidney cancer, liver cancer, pancreatic cancer, and others. Based on end user, the global cancer diagnostics market has been segmented into diagnostic center, clinic, hospital, research institutes, and others.

Global Cancer Diagnostics Market: Regional Analysis
Geographically, the global cancer diagnostics market ha been segmented into four major regions such as the Americas, Asia Pacific, Europe and the Middle East and Africa. The Americas command the major share of the global cancer diagnostics market owing to the high prevalence of individuals suffering from cancer, rapid adoption of advanced technology in order to improve the diagnostics and treatment solutions in the well-developed healthcare infrastructure and increased expenditure on healthcare by the population in this region. Technological advancement is aiding the pharmaceutical industry to carry out extensive research activities for the development of advanced diagnostics procedure in order to provide accurate treatment for curing cancer, which in turn is propelling the growth of the cancer diagnostics market in the Europe region. Increasing awareness regarding the availability of advanced diagnostics procedures in the healthcare sector of emerging economies, rise in prevalence of cancer, and increased government initiatives to support cancer patients to get thorough diagnosis and effective treatments with the help of favorable reimbursement policies are fueling the expansion of the cancer diagnostics market in the Asia Pacific region. Lack of awareness and low penetration of advanced diagnostics solution in the remote areas of the underdeveloped countries are leading to the steady growth of the cancer diagnostics market in the Middle East and Africa market.

Global Cancer Diagnostics Market: Industry Updates
In january 2019, MRM Proteomics inc. has partnered with biodesix which will allow Biodesix to utilize MRM Proteomics's proprietary iMALDI technologies to improve the blood-based lung cancer diagnostics.
In January 2019, Veracyte, a U.S.-based genomic diagnostics comapny has partnered with Johnson & Johnson Innovation for the development and commercialization of new tests for detection of lung cancer during the early stages.
In January 2019, ArcherDx, The Boulder CO-based company has announced that it has been granted with Breakthrough Device Designation for its tissue specimen diagnostic and liquid biopsy application for effective cancer diagnostic.

Intended Audience
  • Cancer specific medical device manufacturers
  • Cancer specific medical device suppliers
  • Government Research Laboratory
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
Hottest Trending Reports

 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)